Q2 2025 Management View Doug Black, Chairman and CEO, stated that "we are pleased to achieve continued solid results during ...

Agriculture products company SiteOne Landscape Supply (NYSE:SITE) met Wall Street’s revenue expectations in Q2 CY2025, with ...

Shares of agriculture products company SiteOne Landscape Supply (NYSE:SITE) jumped 10.1% in the afternoon session after the ...

Shares of SiteOne Landscape Supply (NYSE:SITE) jumped as much as 11% on Wednesday to their highest level since mid-February, ...

Despite the miss, SiteOne improved its profitability metrics, with Adjusted EBITDA increasing 8% to $226.7 million and Adjusted EBITDA margin expanding by 60 basis points to 15.5%. Gross profit rose 4 ...

ROSWELL, Ga. (AP) — ROSWELL, Ga. (AP) — SiteOne Landscape Supply, Inc. (SITE) on Wednesday reported second-quarter profit of $129 million. The Roswell, Georgia-based company said it had net income of ...

SiteOne Landscape Supply, Inc., together with its subsidiaries, engages in the wholesale distribution of landscape supplies in the United States and Canada. The company provides irrigation ...

SiteOne Landscape Supply, Inc. (NYSE: SITE), is the largest and only national full product line wholesale distributor of landscape supplies in the United States and has a growing presence in Canada.

Review quarterly and annual revenue, net income, and cash flow for SiteOne Landscape Supply Inc (SITE:XNYS) stock through the last fiscal year.

Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds SiteOne Therapeutics develops drugs that target sodium channels, the “wiring” in the body that transmits pain signals.

SiteOne Therapeutics is a biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting Na V 1.7, Na V 1.8, and other voltage-gated ion channels to ...

SiteOne’s drug candidate, STC-004, is on track to begin Phase 2 testing. SiteOne develops drugs that target sodium channels, which are found primarily in the peripheral nervous system.